Cellular Barcoding Identifies Clonal Substitution as a Hallmark of Local Recurrence in a Surgical Model of Head and Neck Squamous Cell Carcinoma
Vincent Roh,
Pierre Abramowski,
Agnès Hiou-Feige,
Kerstin Cornils,
Jean-Paul Rivals,
Alexandre Zougman,
Tim Aranyossy,
Lars Thielecke,
Zinnia Truan,
Maxime Mermod,
Yan Monnier,
Vladimir Prassolov,
Ingmar Glauche,
Ali Nowrouzi,
Amir Abdollahi,
Boris Fehse,
Christian Simon,
Genrich V. Tolstonog
Affiliations
Vincent Roh
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland
Pierre Abramowski
Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
Agnès Hiou-Feige
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland
Kerstin Cornils
Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
Jean-Paul Rivals
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland
Alexandre Zougman
Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute of Cancer and Pathology, St. James’s University Hospital, Leeds, UK
Tim Aranyossy
Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
Lars Thielecke
Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustave Carus, Technische Universität Dresden, Dresden, Germany
Zinnia Truan
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland
Maxime Mermod
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland
Yan Monnier
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland
Vladimir Prassolov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia
Ingmar Glauche
Institute for Medical Informatics and Biometry, Faculty of Medicine Carl Gustave Carus, Technische Universität Dresden, Dresden, Germany
Ali Nowrouzi
German Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Core Center Heidelberg, Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Heidelberg University Hospital (UKHD) and DKFZ, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany
Amir Abdollahi
German Cancer Consortium (DKTK), Translational Radiation Oncology, German Cancer Research Center (DKFZ), Core Center Heidelberg, Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Heidelberg University Hospital (UKHD) and DKFZ, Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany
Boris Fehse
Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Corresponding author
Christian Simon
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland; Corresponding author
Genrich V. Tolstonog
Department of Otolaryngology – Head and Neck Surgery, University Hospital of Lausanne, Lausanne, Switzerland; Corresponding author
Summary: Local recurrence after surgery for head and neck squamous cell carcinoma (HNSCC) remains a common event associated with a dismal prognosis. Improving this outcome requires a better understanding of cancer cell populations that expand from postsurgical minimal residual disease (MRD). Therefore, we assessed clonal dynamics in a surgical model of barcoded HNSCC growing in the submental region of immunodeficient mice. Clonal substitution and massive reduction of clonal heterogeneity emerged as hallmarks of local recurrence, as the clones dominating in less heterogeneous recurrences were scarce in their matched primary tumors. These lineages were selected by their ability to persist after surgery and competitively expand from MRD. Clones enriched in recurrences exhibited both private and shared genetic features and likely originated from ancestors shared with clones dominating in primary tumors. They demonstrated high invasiveness and epithelial-to-mesenchymal transition, eventually providing an attractive target for obtaining better local control for these tumors. : Roh et al. combine fluorescent protein marking and cellular barcoding to investigate the clonal composition of matched primary and recurrent tumors in a surgical model of HNSCC. They demonstrate that clones present in primary tumors are substituted by other initially rare clones expanding after resection. Keywords: head and neck squamous cell carcinoma, clonal heterogeneity, clonal substitution, recurrent tumor-initiating clones, epithelial-mesenchymal transition, invasion, RGB marking, DNA barcoding, LeGO vectors